Safety and efficacy of Siddha formulations viz., Thiriloga Chenduram and Annabedhi chendhuram in the treatment of Veluppu noi (Iron Deficiency Anaemia).
Phase 2
- Conditions
- Health Condition 1: D509- Iron deficiency anemia, unspecified
- Registration Number
- CTRI/2022/10/046708
- Lead Sponsor
- Central Council for Research in Siddha Ministry of AYUSH Govt of India Chennai
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
a. Haemoglobin level between 6 and 10 gm/dl
b. Presence of any four of the following clinical findings
i. Serum Iron content below 50 µg/l
ii. Serum Ferritin below 30 µg/l
iii. Haematocrit/ PCV below 35%
iv. TIBC below 200 µg/l
v. MCHC level below 34 g/dl
vi. MCV level below 80 fl
vii. Peripheral blood smear showing Hypochromic & Microcytic Anaemia
Exclusion Criteria
a. Pregnant Women & Lactating Mothers
b. Severe Renal, Hepatic & Cardiac diseases
c. Known case of Diabetes mellitus & Hypertension
d. Other clinical conditions like Bleeding Piles, Haemetemesis, Maleana etc, Causing frequent blood loss
e. Dimorphic Anaemia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method i. Safety and Efficacy of the trial drug Thiriloga Chenduram <br/ ><br>ii. Biochemical changes in Blood and RBC (Before and After treatment)Timepoint: Laboratory Investigations will be performed on 0th, 15th, 30th & 46th day.
- Secondary Outcome Measures
Name Time Method iii. Substantiate the prognosis of the patient even after therapyTimepoint: Blood investigations will be done on 1st, 3rd and 6th month after the treatment period of 45 days.